Jing Chen Xiao

823 total citations
20 papers, 313 citations indexed

About

Jing Chen Xiao is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jing Chen Xiao has authored 20 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 11 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Jing Chen Xiao's work include Cannabis and Cannabinoid Research (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Antibiotic Resistance in Bacteria (5 papers). Jing Chen Xiao is often cited by papers focused on Cannabis and Cannabinoid Research (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Antibiotic Resistance in Bacteria (5 papers). Jing Chen Xiao collaborates with scholars based in United States, France and China. Jing Chen Xiao's co-authors include Tung M. Fong, Chun-Pyn Shen, Julie Lao, William K. Hagmann, Junying Wang, Xinchun Tong, Thomas F. Walsh, Jeffrey J. Hale, Linus S. Lin and D. Sloan Stribling and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jing Chen Xiao

20 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Chen Xiao United States 12 197 123 93 76 55 20 313
Mark D. Bauer United States 10 152 0.8× 69 0.6× 180 1.9× 10 0.1× 60 1.1× 14 438
Yasuharu Kimura Japan 11 134 0.7× 204 1.7× 229 2.5× 67 0.9× 64 1.2× 14 467
Takao Okuda Japan 9 81 0.4× 10 0.1× 49 0.5× 28 0.4× 80 1.5× 29 271
Eleonora Diamanti Germany 11 38 0.2× 47 0.4× 131 1.4× 71 0.9× 16 0.3× 33 264
Marco Turconi Italy 13 44 0.2× 165 1.3× 212 2.3× 151 2.0× 9 0.2× 22 404
Mohammed A. Sayed Egypt 9 41 0.2× 26 0.2× 148 1.6× 88 1.2× 60 1.1× 15 395
Goutham R. Adelli United States 11 90 0.5× 15 0.1× 112 1.2× 20 0.3× 16 0.3× 15 486
Thomas W. Flanagan United States 12 29 0.1× 160 1.3× 128 1.4× 128 1.7× 6 0.1× 24 491
Justyna Kulpa United States 11 161 0.8× 31 0.3× 165 1.8× 21 0.3× 9 0.2× 24 410
Sharon Pan United States 12 57 0.3× 53 0.4× 66 0.7× 68 0.9× 4 0.1× 37 346

Countries citing papers authored by Jing Chen Xiao

Since Specialization
Citations

This map shows the geographic impact of Jing Chen Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Chen Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Chen Xiao more than expected).

Fields of papers citing papers by Jing Chen Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Chen Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Chen Xiao. The network helps show where Jing Chen Xiao may publish in the future.

Co-authorship network of co-authors of Jing Chen Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Chen Xiao. A scholar is included among the top collaborators of Jing Chen Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Chen Xiao. Jing Chen Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carr, Donna, Zufei Zhang, Qian Si, et al.. (2020). In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa. Open Forum Infectious Diseases. 7(11). ofaa469–ofaa469. 3 indexed citations
2.
Wu, Jin, Fred Racine, Michael K. Wismer, et al.. (2018). Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 62(5). 46 indexed citations
3.
Xiao, Jing Chen, et al.. (2017). Some Results on Pareto Optimal Choice Sets for Estimating Main Effects and Interactions in 2 n and 3 n Factorial Plans. Sankhya B. 80(1). 37–59. 1 indexed citations
4.
Labroli, Marc, John P. Caldwell, Christine Yang, et al.. (2016). Discovery of potent wall teichoic acid early stage inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(16). 3999–4002. 9 indexed citations
5.
Yang, Shu‐Wei, Jianping Pan, Christine Yang, et al.. (2016). Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 26(19). 4743–4747. 11 indexed citations
6.
Xiao, Jing Chen, Yun Shi, Hui Chen, et al.. (2015). Identification and Validation Novel of VIM‐2 Metallo‐β‐lactamase Tripeptide Inhibitors. Molecular Informatics. 34(8). 559–567. 5 indexed citations
7.
Dillon, Gregory M., Laura S. Lubbers, Julie Lao, et al.. (2011). MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice. Behavioural Pharmacology. 22(2). 91–100. 9 indexed citations
8.
9.
Debenham, John S., Thomas F. Walsh, Lin Yan, et al.. (2010). Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 20(12). 3750–3754. 8 indexed citations
10.
Debenham, John S., Thomas F. Walsh, Junying Wang, et al.. (2010). Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1. Bioorganic & Medicinal Chemistry Letters. 20(4). 1448–1452. 25 indexed citations
11.
Du, Wu, James P. Jewell, Linus S. Lin, et al.. (2009). Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5195–5199. 7 indexed citations
12.
Debenham, John S., Junying Wang, Xinchun Tong, et al.. (2009). Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 19(9). 2591–2594. 16 indexed citations
13.
Fong, Tung M., Lauren P. Shearman, D. Sloan Stribling, et al.. (2009). Pharmacological efficacy and safety profile of taranabant in preclinical species. Drug Development Research. 70(5). 349–362. 12 indexed citations
14.
Xiao, Jing Chen, James P. Jewell, Linus S. Lin, et al.. (2008). Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells. Brain Research. 1238. 36–43. 15 indexed citations
15.
Chen, Richard Z., Andrea Frassetto, Julie Lao, et al.. (2008). Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor. European Journal of Pharmacology. 584(2-3). 338–342. 38 indexed citations
16.
17.
Debenham, John S., Thomas F. Walsh, Junying Wang, et al.. (2007). Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 17(7). 2031–2035. 11 indexed citations
18.
Shen, Chun-Pyn, et al.. (2006). F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist. European Journal of Pharmacology. 531(1-3). 41–46. 18 indexed citations
19.
Zhang, Ping, Chun-Pyn Shen, Jing Chen Xiao, et al.. (2006). Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor. European Journal of Pharmacology. 534(1-3). 77–82. 11 indexed citations
20.
Debenham, John S., Thomas F. Walsh, Junying Wang, et al.. (2005). Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 16(3). 681–685. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark D. Bauer Breakdown of academic impact, for papers by Yasuharu Kimura Breakdown of academic impact, for papers by Takao Okuda Breakdown of academic impact, for papers by Eleonora Diamanti Breakdown of academic impact, for papers by Marco Turconi Breakdown of academic impact, for papers by Mohammed A. Sayed Breakdown of academic impact, for papers by Goutham R. Adelli Breakdown of academic impact, for papers by Thomas W. Flanagan Breakdown of academic impact, for papers by Justyna Kulpa Breakdown of academic impact, for papers by Sharon Pan
Rankless by CCL
2026